0
0
3/18/26 at 6:06pm
Organization
CNBC
Author
Annika Kim Constantino
44 words
0
Comments
Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in patients with Type 2 diabetes.
You are the first to view
https://www.cnbc.com/2026/03/18/stopping-glp-1s-raises-cardiovascular-risks-study.html
Create an account
or login to join the discussion